Akt2 Antibodies

Santa Cruz Biotechnology provides a broad selection of Akt2 monoclonal antibodies for research focused on understanding the Akt signaling pathway. Akt2 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Akt2, a member of the Akt family of serine/threonine kinases, plays a crucial role in regulating cell survival, growth, and metabolism. Akt2 influences various cellular processes, including glucose metabolism, protein synthesis, and apoptosis, making it a significant target in cancer research and therapeutic development. Understanding Akt2 function is essential for elucidating its role in oncogenesis and other diseases. Researchers worldwide rely on Akt2 monoclonal antibodies to advance their studies in cell signaling mechanisms. The specificity and reliability of Akt2 monoclonal antibodies enable precise detection and analysis of protein expression and activation states. Santa Cruz Biotechnology monoclonal antibodies for Akt2 continue to support breakthrough discoveries in cancer research and cellular biology, contributing to the advancement of scientific knowledge.